-
Mashup Score: 0
While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial behavioral health diagnosis.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0Unveiling the Future of Specialty Pharmacy at AXS24 - 16 hour(s) ago
Asembia AXS24, which has record registration this year, will take place in Las Vegas, Nevada, April 28-May 2, at the Wynn & Encore Las Vegas.
Source: www.ajmc.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 2
A panel of experts provide an overview of gene therapy, review recently approved gene therapies for rare diseases such as hemophilia, spinal muscular atrophy, and Duchenne muscular dystrophy, and discuss managed care considerations, focusing on the growing pipeline of therapies.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 1Vitamin D Supplementation Linked to Reduced In-Hospital, ICU Mortality in Patients With COPD - 3 day(s) ago
Vitamin D supplementation may decrease in-hospital and intensive care unit (ICU) mortality in patients with chronic obstructive pulmonary disease (COPD), a study found.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2
The FDA has approved fidanacogene elaparvovec-dzkt (Beqvez; Pfizer), a gene therapy administered in a one-time dose, for certain patients with moderate to severe hemophilia B.
Source: www.ajmc.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 1What We’re Reading: Kaiser Permanente Data Breach; GSK Sues Pfizer, BioNTech; HIV Infections via Cosmetic Injections - 3 day(s) ago
Kaiser Permanente was hit by a data breach in mid-April, impacting 13.4 million health plan members; GlaxoSmithKline (GSK) sued Pfizer and BioNTech for allegedly infringing on its messenger RNA technology patents in the companies’ COVID-19 vaccines; the CDC announced the first-known HIV cases transmitted via cosmetic injections.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Melatonin Fails to Ease Fatigue in Patients With Early-Stage Breast Cancer Undergoing Radiotherapy - 4 day(s) ago
Melatonin showed no benefit for cancer-related fatigue or other symptoms in women with early-stage breast cancer receiving radiotherapy treatment.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Dr Ryan Stice Shares Strategy on Expanding Access to Care With Virtual Population Health Teams - 4 day(s) ago
In an interview during The American Journal of Managed Care®’s Institute for Value-Based Medicine® event, held with Sutter Health, Ryan Stice, PharmD, BCPS, explains the impact virtual population health teams can have on improving access to care for patients with cardiometabolic conditions.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0Talquetamab Cost-Effective Breakthrough for RRMM - 4 day(s) ago
The FDA granted accelerated approval to talquetamab on August 9, 2023, as a treatment option for adult patients with relapsed/refractory multiple myeloma (RRMM) who have failed at least 4 prior lines of therapy.
Source: www.ajmc.comCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 2Optimizing BTK Inhibitors in CLL and SLL - 5 day(s) ago
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.
Source: www.ajmc.comCategories: General Medicine News, PayerTweet
While behavioral health care utilization has been rising, the treatment landscape has been worsening. New findings show that 20% of youths did not receive any form of treatment within 3 months of their initial #behavioralhealth diagnosis. Learn more here: https://t.co/Gcu3HWipSr https://t.co/NsrceOZ8xV